Salt and blood pressure: Time to challenge

Cardiology

Volumn 105, Issue 1, 2005, Pages 9-16

  Altun, Bulent ^a   Arici, Mustafa ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Blood pressure; Clinical trials; Meta analysis; Sodium reduction

Indexed keywords

SODIUM CHLORIDE;

BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL TRIAL; DIET; HUMAN; HYPERTENSION; META ANALYSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SALT INTAKE; SODIUM URINE LEVEL; SYSTEMATIC REVIEW;

ANIMALS; BLOOD PRESSURE; CLINICAL TRIALS; HUMANS; HYPERTENSION; KIDNEY; NATRIURESIS; RISK FACTORS; SODIUM, DIETARY;

EID: 33144461524     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088265     Document Type: Review

References (71)

1. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense H-W, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodriguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F: Hypertension prevalence and blood pressure in 6 European countries, Canada, and the United States. JAMA 2003;289:2363-2369.
2. Vasan RS, Larson MG, Leip EP, Kannel WP, Levy D: Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001;358:1682-1686.
3. Dahl LK, Heine M, Thompson K: Genetic influence of the kidneys on blood pressure. Evidence from chronic renal homografts in rats with opposite predispositions to hypertension. Circ Res 1974;40:94-101.
4. Rettig R, Folberth C, Stauss H, Kopf D, Waldherr R, Unger T: Role of the kidney in primary hypertension: a renal transplantation study in rats. Am J Physiol 1990;258:F606-F611.
5. Borst JGG, Borst-de-Geus A: Hypertension explained by Starling's theory of circulatory homeostasis. Lancet 1963;i:677-682.
6. De Wardener HE: Franz Volhard lecture 1996. Sodium transport inhibitors and hypertension. J Hypertens 1996;14(suppl 5):S9-S18.
7. Chobanian AV, Hill M: National Heart, Lung, and Blood Institute Workshop on Sodium and Blood Pressure. A critical review of current scientific evidence. Hypertension 2000;35:858-863.
8. He J, Whelton PK: Commentary: Salt intake, hypertension and risk of cardiovascular disease: An important public health challenge. Int J Epidemiol 2002;31:327-331.
9. Meneton P, Warnock DG: Involvement of renal apical Na transport systems in the control of blood pressure. Am J Kidney Dis 2001; 37(suppl 2):S39-S47.
10. Carvalho JJM, Baruzzi RG, Howard PF, et al: Blood pressure in four remote populations in the INTERSALT study. Hypertension 1989;14:238-246.
11. Poulter N, Khaw KT, Hopwood BE, et al: The Kenyan Luo migration study: observations on the initiation of a rise in blood pressure. BMJ 1990;300:967-972.
12. Klag MJ, He J, Coresh J, et al: The contribution of urinary cations to the blood pressure differences associated with migration. Am J Epidemiol 1995;142:295-303.
13. Intersalt Cooperative Research Group. Intersalt: An international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ 1988;297:319-328.
14. Stamler J: The INTERSALT study: background, methods, findings, and implications. Am J Clin Nutr 1997;65(suppl):626S-642S.
15. Law MR, Frost CD, Wald NJ: By how much does dietary salt reduction lower blood pressure? I: Analysis of observational data among populations. BMJ 1991;302:811-815.
16. Denton D, Weisinger R, Mundy NI, et al: The effect of increased salt intake on blood pressure of chimpanzees. Nature Med 1995;1:1009-1016.
17. Lang F, Capasso G, Schwab M, Waldegger S: Renal tubular transport and the genetic basis of hypertensive disease. Clin Exp Nephrol 2005;9:91-99.
18. Lifton RP: Molecular genetics of human blood pressure variation. Science 1996;272:676-680.
19. Dominiczak AF, Negrin DC, Clark JS, Brosnan MJ, McBride MW, Alexander MY: Genes and hypertension. From gene mapping in experimental models to vascular gene transfer strategies. Hypertension 2000;35(pt 2):164-172.
20. Kaplan NM: Kaplan's Clinical Hypertension, ed 8. Philadelphia, Lippincott, Williams & Wilikins, 2002, pp 213-218.
21. Midgley JP, Matthew AG, Greenwood CMT, Logan AG: Effect of reduced dietary sodium on blood pressure: A meta-analysis of randomized controlled trials. JAMA 1996;275:1590-1597.
22. Cutler JA, Follmann D, Allender PS: Randomized trials of sodium reduction: An overview. Am J Clin Nutr 1997;65(suppl):643S-651S.
23. Graudal NA, Galløe AM, Garred P: Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride: A meta-analysis. JAMA 1998;279:1383-1389.
24. Alam S, Johnson AG: A meta-analysis of randomised controlled trials (RCT) among healthy normotensive and essential hypertensive elderly patients to determine the effect of high salt (NaCl) diet on blood pressure. J Hum Hypertens 1999;13:367-374.
25. Hooper L, Bartlett C, Smith GD, Ebrahim S: Systematic review of long term effects of advice to reduce dietary salt in adults. BMJ 2002;325:628-636.
26. He FJ, MacGregor GA: Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens 2002;16:761-770.
27. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-1913.
28. Chrysant SG, Weder AB, McCarron DA, et al: Effects of isradipine or enalapril on blood pressure in salt-sensitive hypertensives during low and high dietary salt intake. Am J Hypertens 2000;13:1180-1188.
29. Singer DRJ, Markandu ND, Cappucio FP, Miller MA, Sagnella GA, MacGregor GA: Reduction of salt intake during converting enzyme inhibitor treatment compared with addition of a thiazide. Hypertension 1995;25:1042-1044.
30. Buter H, Hemmelder MH, Navis G, de Jong PE, de Zeeuw D: The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide. Nephrol Dial Transplant 1998;13:1682-1685.
31. Houlihan CA, Allen TJ, Baxter AL, et al: A low-sodium diet potentiates the effects of losartan in type 2 diabetes. Diabetes Care 2002;25:663-671.
32. De Nicola L, Minutolo R, Bellizzi V, et al: Achievement of target blood pressure levels in chronic kidney disease: A salty question? Am J Kidney Dis 2004;43:782-795.
33. Koomans HA, Roose JC, Mees EJD, Delawi IMK: Sodium balance in renal failure: A comparison with normal subjects under extremes of sodium intake. Hypertension 1985;7:714-721.
34. Forte JG, Miguel JM, Miguel MJ, de Padua F, Rose G: Salt and blood pressure: a community trial. J Hum Hypertens 1989;3:179-184.
35. Forrester T, Adeyemo A, Soarres-Wynter S, et al: A randomized trial on sodium reduction in two developing countries. J Hum Hypertens 2005;19:55-60.
36. Hofman A, Hazebroek A, Valkenburg HA: A randomized trial of sodium intake and blood pressure in newborn infants. JAMA 1983, 250:370-373.
37. Geleijnse JM, Hofman A, Witteman JC, Hazebroek AA, Valkenburg HA, Grobbee DE: Long-term effects of neonatal sodium restriction on blood pressure. Hypertension 1997;29:913-917.
38. Sacks FM, Svetkey LP, Vollmer WM, et al: Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med 2001;344:3-10.
39. Vollmer WM, Sacks FM, Ard J, et al: Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med 2001;135:1019-1028.
40. The Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. Arch Intern Med 1997;157:657-667.
41. Kumanyika SK, Cook NR, Cutler JA, et al for the Trials of Hypertension Prevention Collaborative Research Group: Sodium reduction for hypertension prevention in overweight adults: further results from the Trials of Hypertension Prevention Phase II. J Hum Hypertens 2005;19:33-45.
42. Ohta Y, Tsuchihashi T, Ueno M, et al: Relationship between the awareness of salt restriction and the actual salt intake in hypertensive patients. Hypertens Res 2004;27:243-246.
43. Staessen JA, Lijnen P, Thijs L, Fagard R: Salt and blood pressure in community-based intervention trials. Am J Clin Nutr 1997;65(suppl): 661S-670S.
44. Graudal N, Galloe A: Should dietary salt restriction be a basic component of antihypertensive therapy. Cardiovasc Drugs Ther 2000;14:381-386.
45. Chobanian AV, Bakris GL, Black HR, et al and the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-1252.
46. MacGregor GA, Sever PS: Salt - overwhelming evidence but still no action: Can a consensus be reached with the food industry? BMJ 1996;312:1287-1289.
47. Kawasaki T, Delea CS, Bartter FC, Smith H: The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. Am J Med 1978;64:193-198.
48. Weinberger MH, Miller JZ, Luft FC, Grim CE, Fineberg NS: Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 1986;8(suppl 2):II127-II134.
49. Weinberger MH: Salt sensitivity of blood pressure in humans. Hypertension 1996;27:481-490.
50. Suzuki M, Kimura Y, Tsushima M, Harano Y: Association of insulin resistance with salt sensitivity and nocturnal fall in blood pressure. Hypertension 2000;35:864-868.
51. Bihorac A, Tezcan H, Ozener C, Oktay A, Akoglu E: Association between salt sensitivity and target organ damage in essential hypertension. Am J Hypertens 2000;13:864-872.
52. Chiolero A, Würzner G, Burnier M: Renal determinants of the salt sensitivity of blood pressure. Nephrol Dial Transplant 2001;16:452-458.
53. Weinberger MH, Fineberg NS, Fineberg SE, Weinberger M: Salt sensitivity, pulse pressure and death in normal and hypertensive humans. Hypertension 2001;37:429-432.
54. Guyton AC: Physiologic regulation of arterial pressure. Am J Cardiol 1961;8:401-407.
55. Guyton AC: Kidneys and fluids in pressure regulation. Small volume but large pressure changes. Hypertension 1992;19(suppl 1):I2-I8.
56. Dahl LK, Heine M: Primary role of renal homographs in setting chronic blood pressure and levels in rats. Circ Res 1975;36:692-696.
57. Curtis JJ, Luke RG, Dustan HP, et al: Remission of essential hypertension after renal transplantation. N Engl J Med 1983;309:1009-1015.
58. Dahl LK: Humoral transmission of hypertension. Circ Res 1969;24:I21-I33.
59. Blaustein MP: Endogenous ouabain: role in the pathogenesis of hypertension. Kidney Int 1996;49:1748-1753.
60. de Wardener HE, MacGregor GA: Dahl's hypothesis that a saluretic substance may be responsible for a sustained rise in arterial pressure. Kidney Int 1980;18:1-9.
61. Sealey JE, Blumenfeld JD, Bell GM, Pecker MS, Sommers SC, Laragh JH: On the renal basis of essential hypertension. Nephron heterogeneity with discordant renin secretion and sodium excretion causing a hypertensive vasoconstriction-volume relationship. J Hypertens 1988;6:763-777.
62. Brenner BM, Garcia DL, Anderson S: Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens 1988;1:335-347.
63. Brenner BM, Chertow GM: Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am J Kidney Dis 1994;23:171-175.
64. Keller G, Zimmer G, Mall G, Ritz E, Amann K: Nephron number in patients with primary hypertension. N Engl J Med 2003;348:101-108.
65. Alderman MH: Salt, blood pressure and health: A cautionary tale. Int J Epidemiol 2002;31:311-315.
66. Alderman MH, Madhavan S, Cohen H, Sealey JE, Laragh JH: Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension 1995;25:1144-1152.
67. Alderman MH, Cohen H, Madhavan S: Dietary sodium intake and mortality: The National Health and Nutrition Survey (NHANES I). Lancet 1998;351:781-785.
68. MacGregor G, de Wardener HE: Commentary: Salt, blood pressure and health. Int J Epidemiol 2002;31:320-327.
69. Tuomilehto J, Jousilahti P, Rastenyte D, et al: Urinary sodium excretion and cardiovascular mortality in Finland: A prospective study. Lancet 2001;357:848-851.
70. MacGregor GA: Blood pressure: Importance of the kidney and the need to reduce salt intake. Am J Kidney Dis 2001;37(suppl 2):S34-S38.
71. Messerli FH, Schmieder RE: Salt and hypertension. Going to the heart of the matter. Arch Intern Med 2001;161:505-506.